Menu
Programme Committee
Meet the EuroMeeting Co-chairs
|
|
Karl Broich |
|
Kemal Malik |
A Message from the Co-chairs
Program Committee
-
Karl Broich, DrMed • President
Federal Institute for Drugs and Medical Devices (BfArM), Germany -
Kemal Z. Malik • Member of the Board of Management
Bayer, Germany -
Peter Richard Arlett, MD, FFPM, FRCP • Head Data Analytics and Methods Task Force
European Medicines Agency, Netherlands -
Peter Bachmann • Deputy-Head, European Union and International Affairs
Federal Institute for Drugs and Medical Devices (BfArM), Germany -
Francesca Cerreta, PharmD, MPharm, MS • Principal Scientific Officer
European Medicines Agency, Netherlands -
Michael Devoy •
Bayer AG, Germany -
Petra Doerr, PharmD, RPh • Director
European Directorate for the Quality of Medicines and Healthcare (EDQM), France -
Emma Du Four, MBA • Regulatory and R&D Policy Professional
-, United Kingdom -
Hans-Georg Eichler, MD, MSc • Consulting Physician
Austrian Association of Social Security Bodies, Austria -
Edith Frénoy, MA, MSc • Director, European Public Policy – Strategic EU Advocacy Lead
MSD Europe Inc., Belgium -
Matthias Gottwald • Head R&D Policy and Networking
Bayer Pharma AG, Germany -
Martin Harvey Allchurch, LLM • Head of International Affairs
European Medicines Agency, Netherlands -
Niklas Hedberg, MPharm • HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden -
Sabina Hoekstra-van den Bosch, PharmD, MSc, RPh • Regulatory Strategy Principal
Tüv Süd, Netherlands -
Alastair Kent, MHS • Co-Chair of the UK Rare Disease Policy Board; Former Executive Director
Genetic Alliance UK, United Kingdom -
Maarten Lagendijk, MSc • Deputy EU QPPV
MSD, Netherlands -
Birka Lehmann, MD • Senior Expert Drug Regulatory Affairs
Birka Lehmann, Germany -
Monika Lessl • Head of Innovation Strategy
Bayer AG, Germany -
Sabine Luik • EFPIA Member ICH Steering Committee, Sr Vice President Medicine & Regulatory
Boehringer Ingelheim Pharmaceuticals, United States -
Detlef Nehrdich, MSc • Senior Associate
Waife & Associates, Germany -
Luca Pani, MD • Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences
University of Miami, United States -
Kristin Raudsepp, MD • Head of the Tartu Raatuse Clinic
Confido Medical Center, Estonia -
Holger Maria Rohde, PhD, MBA, MSc • Director Regulatory Project Management
Merck KGaA, Germany -
Thomas Schindler, PhD • Director Global Regulatory Affairs - Regulatory Operations
BioNTech SE, Germany -
Isabelle Stoeckert, PharmD, PMP • VP. Head Regulatory Affairs Europe Middle East Africa PH
Bayer, Germany -
Florian von Raison, DrMed • Senior Global Program Head and Chairman Geriatric Medicine Working Party/ EFGCP
Novartis Pharma AG, Switzerland -
Margaret Anne Walters • Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom -
John Wilkinson • Director of Devices
MHRA, United Kingdom -
Milan Zdravkovic, MD • Senior Vice President, Head of Research & Development
Swedish Orphan Biovitrum AB, Sweden